The FDA has issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test.
Read MoreBiotest Diagnostics Corp (Biotest) announces a multi-year agreement with Premier Purchasing Partners, LP, the group purchasing unit of Premier, Inc., for its advanced serology solutions, including traditional blood bank reagents, and the TANGO® optimo Automated Blood Bank System.
Read MorePrometheus Laboratories Inc announces the nationwide commercial launch of three new cancer diagnostic products, each based on recently developed, highly sensitive microRNA technology.
Read MoreTyrian Diagnostics Limited announced today that Tyrian and BD will not continue their collaboration to develop a Point-of-Care (PoC) test for the diagnosis of active tuberculosis (TB).
Read MoreSerametrix Corp, a personalized medicine company, announces its partnership with the Ludwig Institute for Cancer Research Ltd (LICR).
Read More